Patents by Inventor Carrie M. Rosenberger

Carrie M. Rosenberger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140341908
    Abstract: The invention is directed to an improved method to manufacture virus for use in vaccine by culturing infected cells that have been modified to overexpress miR-144. The invention is also directed to manipulating the activity or level of miR-144 in subjects in order to modulate the antiviral and immune response systems.
    Type: Application
    Filed: May 20, 2014
    Publication date: November 20, 2014
    Applicant: INSTITUTE FOR SYSTEMS BIOLOGY
    Inventors: Carrie M. ROSENBERGER, Alan ADEREM
  • Patent number: 8747860
    Abstract: The invention is directed to an improved method to manufacture virus for use in vaccine by culturing infected cells that have been modified to overexpress miR-144. The invention is also directed to manipulating the activity or level of miR-144 in subjects in order to modulate the antiviral and immune response systems.
    Type: Grant
    Filed: July 5, 2012
    Date of Patent: June 10, 2014
    Assignee: Institute for Systems Biology
    Inventors: Carrie M. Rosenberger, Alan A. Aderem
  • Publication number: 20130022602
    Abstract: The invention is directed to an improved method to manufacture virus for use in vaccine by culturing infected cells that have been modified to overexpress miR-144. The invention is also directed to manipulating the activity or level of miR-144 in subjects in order to modulate the antiviral and immune response systems.
    Type: Application
    Filed: July 5, 2012
    Publication date: January 24, 2013
    Inventors: Carrie M. Rosenberger, Alan A. Aderem
  • Publication number: 20090297552
    Abstract: Vaccines that comprise or generate immunomodulatory flagellin polypeptides able to stimulate an innate immune response intracellularly and extracellularly employ viruses, bacteria or parasitic cells that contain expression systems for such polypeptides, as well as fusion proteins that contain antigens and/or cell penetrating peptides along with the immunomodulatory peptide.
    Type: Application
    Filed: April 24, 2009
    Publication date: December 3, 2009
    Inventors: Alan A. Aderem, Edward A. Miao, Carrie M. Rosenberger